Last updated on March 2017

A Multicenter Trial to Investigate the Efficacy and Safety of Tolvaptan in Patients With Hyponatremia in SIADH


Brief description of study

The objective of this study is to investigate the efficacy and safety of tolvaptan based on the change in serum sodium concentration following administration of tolvaptan oral tablets at 7.5 to 60 mg/day for up to 30 days in patients with hyponatremia in the SIADH.

Clinical Study Identifier: NCT03048747

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations